ASHEVILLE, N.C. — The relative absorption of topical corticosteroids, which can induce cataracts and glaucoma, is 300-fold greater across the eyelids than plantar skin, but pediatric dermatologists need not dwell on this ratio when employing steroids near the eye, according to one of several clinical messages from a pediatric ophthalmologist who spoke here at the annual meeting of the Society for Pediatric Dermatology.
"There is a lot of steroid fear out there, which you can argue is actually harmful in itself, because not treating periorbital eczema is related to a lot of eye problems, including chronic discomfort and the eye rubbing that can cause corneal abrasions and keratoconus," said Sara Grace, MD, a pediatric ophthalmologist who is on the clinical staff at Duke University, Durham, North Carolina. She maintains a practice at North Carolina Eye, Ear, Nose, and Throat in Durham.
Although the risks of periorbital steroid absorption are real, a limited course of low potency topical steroids is generally adequate for common periorbital indications, and these appear to be safe.
"There is insufficient evidence to link weak periocular topical corticosteroids such as desonide or hydrocortisone with ocular complications," said Grace, suggesting that pediatric dermatologists can be reassured when using these medications at low concentrations.